Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety and Tolerability of Antioxidant (AT-001)for Reducing Brain Oxidative Stress
- First Posted Date
- 2012-11-21
- Last Posted Date
- 2014-01-23
- Lead Sponsor
- Alltech Life Sciences Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT01731093
- Locations
- 🇺🇸
University of Kentucky Alzheimer's Disease Research Center, Lexington, Kentucky, United States
News
No news found